The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...

Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhi ...

The FDA approved ribociclib (Kisqali) for adjuvant treatment of high-risk ... Patients with advanced or metastatic breast cancer had a recommended oral dose of 600 mg tablets that were received once ...

RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for treating MBC.

There have been more than 600 mass killings in the United States since 2006.

Sept 3 (Reuters) - Sweden's Volvo (VOLVb.ST), opens new tab will launch a long-range variant of its FH Electric truck, capable of covering up to 600 km (373 miles) on a single charge, its ...

U.S. stocks tumbled Tuesday to their worst day since an early August sell-off, as a week full of updates on the economy got off to a discouragingly weak start. The Standard & Poor’s 500 sank 2.1 ...

“Deadpool & Wolverine” continued to dominate at the box office over Labor Day weekend, holding onto the top spot for a fifth time and hitting $600 million in total U.S. sales, multiple outlets ...

My 600-Lb Life is a reality TV series that covers the difficult weight-loss journey of people dealing with excessive obesity. Each episode highlights Dr. Younan Nowzaradan, a bariatric surgeon who ...

NEW YORK – The European Commission has approved Pfizer's Braftovi (encorafenib) and Mektovi (binimetinib), commercialized in Europe by Pierre Fabre Laboratories, for the treatment of patients with ...